{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:26:27Z","timestamp":1762003587278},"reference-count":0,"publisher":"Cambridge University Press (CUP)","issue":"2","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[1999,10]]},"abstract":"<jats:p>A two-dose mass vaccination programme with a combined vaccine against measles, mumps and \nrubella (MMR) was adopted in the Netherlands in 1987, replacing the selective schoolgirl \nvaccination strategy introduced in 1974. To obtain insight into the effect of mass vaccination \nand the population's immunity, the antibody levels against rubella were studied in the general \nDutch population and in religious groups refusing vaccination. In the national sample, we \nobserved a high prevalence (96\u00b75%) for rubella antibodies in vaccinated cohorts as well as in \nthe older unvaccinated cohorts. No indications of rapidly waning immunity after vaccination \nwere found. There are indications of low virus circulation in the last few years. The very high \nseroprevalence in women at childbearing age is consistent with the few reported cases of \ncongenital rubella syndrome (CRS) at present. However, individuals in the age group of 1\u20139 \nyears who are not vaccinated for religious or other reasons have a considerably lower \nseroprevalence and thus there is a potential risk of a CRS outbreak in the future.<\/jats:p>","DOI":"10.1017\/s0950268899002939","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T09:23:42Z","timestamp":1027761822000},"page":"263-270","source":"Crossref","is-referenced-by-count":21,"title":["Prevalence of antibodies against rubella virus in the Netherlands \n9 years after changing from selective to mass vaccination"],"prefix":"10.1017","volume":"123","author":[{"given":"R.","family":"DE HAAS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"VAN DEN HOF","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. A. M.","family":"BERBERS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. E.","family":"DE MELKER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A. E.","family":"CONYN-VAN SPAENDONCK","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[1999,10,1]]},"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268899002939","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T16:10:51Z","timestamp":1557418251000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268899002939\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["S0950268899002939"],"URL":"https:\/\/doi.org\/10.1017\/s0950268899002939","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10]]}}}